Swyer–James syndrome: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|A rare lung disorder characterized by unilateral hyperlucent lung}} | |||
{{Use dmy dates|date=October 2023}} | |||
== Overview == | == Overview == | ||
'''Swyer–James syndrome''' (also known as '''Swyer–James–Macleod syndrome''') is a rare [[lung disorder]] characterized by a unilateral hyperlucent lung, which is typically the result of post-infectious obliterative [[bronchiolitis]] in childhood. This condition leads to decreased vascularity and air trapping in the affected lung, often resulting in a smaller, less dense lung on [[chest X-ray]]. | |||
The | == Pathophysiology == | ||
The underlying mechanism of Swyer–James syndrome involves damage to the small airways, or bronchioles, usually following a severe [[respiratory infection]] such as [[adenovirus]] or [[measles]] during childhood. This damage leads to obliterative bronchiolitis, which causes air trapping and reduced perfusion in the affected lung. The result is a lung that appears hyperlucent on imaging due to decreased blood flow and increased air content. | |||
== Clinical | == Clinical Presentation == | ||
Patients with Swyer–James syndrome may be asymptomatic or present with symptoms such as chronic [[cough]], [[dyspnea]] (shortness of breath), and recurrent [[respiratory infections]]. The condition is often discovered incidentally during imaging for other reasons. | |||
== Diagnosis == | == Diagnosis == | ||
[[File:Swyer2.jpg|thumb|right|Chest X-ray showing unilateral hyperlucent lung characteristic of Swyer–James syndrome.]] | |||
Diagnosis of Swyer–James syndrome is primarily based on imaging studies. A chest X-ray typically reveals a unilateral hyperlucent lung with reduced vascular markings. [[Computed tomography]] (CT) scans can provide more detailed information, showing air trapping and decreased lung volume on the affected side. Pulmonary function tests may show obstructive patterns. | |||
== Treatment == | == Treatment == | ||
There is no specific treatment for Swyer–James syndrome. Management focuses on controlling symptoms and preventing complications. This may include [[bronchodilator]] therapy, [[antibiotics]] for infections, and [[vaccination]] against respiratory pathogens. In severe cases, surgical intervention such as [[lobectomy]] may be considered. | |||
The | == Prognosis == | ||
The prognosis for individuals with Swyer–James syndrome varies. Many patients lead normal lives with minimal symptoms, while others may experience recurrent infections and progressive respiratory issues. Regular follow-up with a healthcare provider is recommended to monitor lung function and manage any complications. | |||
[[ | == Related pages == | ||
[[ | * [[Bronchiolitis]] | ||
[[ | * [[Pulmonary function test]] | ||
* [[Respiratory infection]] | |||
[[Category:Respiratory diseases]] | |||
[[Category:Rare diseases]] | |||
Revision as of 11:17, 15 February 2025
A rare lung disorder characterized by unilateral hyperlucent lung
Overview
Swyer–James syndrome (also known as Swyer–James–Macleod syndrome) is a rare lung disorder characterized by a unilateral hyperlucent lung, which is typically the result of post-infectious obliterative bronchiolitis in childhood. This condition leads to decreased vascularity and air trapping in the affected lung, often resulting in a smaller, less dense lung on chest X-ray.
Pathophysiology
The underlying mechanism of Swyer–James syndrome involves damage to the small airways, or bronchioles, usually following a severe respiratory infection such as adenovirus or measles during childhood. This damage leads to obliterative bronchiolitis, which causes air trapping and reduced perfusion in the affected lung. The result is a lung that appears hyperlucent on imaging due to decreased blood flow and increased air content.
Clinical Presentation
Patients with Swyer–James syndrome may be asymptomatic or present with symptoms such as chronic cough, dyspnea (shortness of breath), and recurrent respiratory infections. The condition is often discovered incidentally during imaging for other reasons.
Diagnosis
Diagnosis of Swyer–James syndrome is primarily based on imaging studies. A chest X-ray typically reveals a unilateral hyperlucent lung with reduced vascular markings. Computed tomography (CT) scans can provide more detailed information, showing air trapping and decreased lung volume on the affected side. Pulmonary function tests may show obstructive patterns.
Treatment
There is no specific treatment for Swyer–James syndrome. Management focuses on controlling symptoms and preventing complications. This may include bronchodilator therapy, antibiotics for infections, and vaccination against respiratory pathogens. In severe cases, surgical intervention such as lobectomy may be considered.
Prognosis
The prognosis for individuals with Swyer–James syndrome varies. Many patients lead normal lives with minimal symptoms, while others may experience recurrent infections and progressive respiratory issues. Regular follow-up with a healthcare provider is recommended to monitor lung function and manage any complications.
